SARAH WHITTLE to Osteosarcoma
This is a "connection" page, showing publications SARAH WHITTLE has written about Osteosarcoma.
Connection Strength
0.752
-
Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task Force. Pediatr Blood Cancer. 2021 09; 68(9):e29188.
Score: 0.570
-
Lenvatinib Plus Ifosfamide and Etoposide in Children and Young Adults With Relapsed Osteosarcoma: A Phase 2 Randomized Clinical Trial. JAMA Oncol. 2024 12 01; 10(12):1645-1653.
Score: 0.181